You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Prochlorperazine edisylate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for prochlorperazine edisylate and what is the scope of patent protection?

Prochlorperazine edisylate is the generic ingredient in three branded drugs marketed by Glaxosmithkline, Alpharma Us Pharms, Morton Grove, Baxter Hlthcare, Amneal, Avet Lifesciences, Caplin, Eugia Pharma, Gland Pharma Ltd, Hikma, Hospira, Marsam Pharms Llc, Mylan Labs Ltd, Nexus, Sagent, Smith And Nephew, Somerset Theraps Llc, Teva Parenteral, Viwit Pharm, Watson Labs, and Wyeth Ayerst, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for prochlorperazine edisylate. Seventeen suppliers are listed for this compound.

Summary for prochlorperazine edisylate
US Patents:0
Tradenames:3
Applicants:21
NDAs:29
Drug Master File Entries: 9
Finished Product Suppliers / Packagers: 17
Raw Ingredient (Bulk) Api Vendors: 35
Patent Applications: 513
What excipients (inactive ingredients) are in prochlorperazine edisylate?prochlorperazine edisylate excipients list
DailyMed Link:prochlorperazine edisylate at DailyMed
Pharmacology for prochlorperazine edisylate
Drug ClassPhenothiazine

US Patents and Regulatory Information for prochlorperazine edisylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gland Pharma Ltd PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 214107-001 Sep 22, 2021 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Eugia Pharma PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 213873-001 Jul 14, 2022 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 214192-001 Nov 28, 2022 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Caplin PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 214379-001 Apr 22, 2021 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alpharma Us Pharms PROCHLORPERAZINE prochlorperazine edisylate CONCENTRATE;ORAL 087153-001 Jun 8, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Smith And Nephew PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 089251-001 Dec 4, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.